Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2013 2
2014 1
2015 3
2016 2
2018 1
2019 2
2020 2
2021 1
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Pouessel D, Ken S, Gouaze-Andersson V, Piram L, Mervoyer A, Larrieu-Ciron D, Cabarrou B, Lusque A, Robert M, Frenel JS, Uro-Coste E, Olivier P, Mounier M, Sabatini U, Sanchez EH, Zouitine M, Berjaoui A, Cohen-Jonathan Moyal E. Pouessel D, et al. Among authors: ken s. Oncologist. 2023 Sep 7;28(9):825-e817. doi: 10.1093/oncolo/oyad095. Oncologist. 2023. PMID: 37196069 Free PMC article. Clinical Trial.
Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis.
Sidibe I, Tensaouti F, Gilhodes J, Cabarrou B, Filleron T, Desmoulin F, Ken S, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lotterie JA, Roques M, Péran P, Cohen-Jonathan Moyal E, Laprie A. Sidibe I, et al. Among authors: ken s. Radiother Oncol. 2023 Apr;181:109486. doi: 10.1016/j.radonc.2023.109486. Epub 2023 Jan 24. Radiother Oncol. 2023. PMID: 36706959 Clinical Trial.
MRI in medical practice and its future use in radiation oncology. Resume of XXV GOCO Congress (Montpellier) 2017.
Druet X, Acosta Sanchez E, Soleakhena K, Laprie A, Sáez J, Nougaret S, Riou O, Rigal E, Kibranian L, Palacios M, Membrive I. Druet X, et al. Among authors: soleakhena k. Rep Pract Oncol Radiother. 2019 Jul-Aug;24(4):355-362. doi: 10.1016/j.rpor.2019.05.003. Epub 2019 Jun 5. Rep Pract Oncol Radiother. 2019. PMID: 31194172 Free PMC article. Review.
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
Laprie A, Noel G, Chaltiel L, Truc G, Sunyach MP, Charissoux M, Magne N, Auberdiac P, Biau J, Ken S, Tensaouti F, Khalifa J, Sidibe I, Roux FE, Vieillevigne L, Catalaa I, Boetto S, Uro-Coste E, Supiot S, Bernier V, Filleron T, Mounier M, Poublanc M, Olivier P, Delord JP, Cohen-Jonathan-Moyal E. Laprie A, et al. Among authors: ken s. Neuro Oncol. 2024 Jan 5;26(1):153-163. doi: 10.1093/neuonc/noad119. Neuro Oncol. 2024. PMID: 37417948 Clinical Trial.
Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?
Tensaouti F, Desmoulin F, Gilhodes J, Martin E, Ken S, Lotterie JA, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lubrano V, Péran P, Cohen-Jonathan Moyal E, Laprie A. Tensaouti F, et al. Among authors: ken s. Magn Reson Med. 2022 Apr;87(4):1688-1699. doi: 10.1002/mrm.29098. Epub 2021 Nov 26. Magn Reson Med. 2022. PMID: 34825724
21 results